Who
Kevin Lorenz
Director
Company insider
Files Form 4 as: Director, Fortress Biotech.
In numbers
- Trades disclosed
- 8
- Buys
- 2
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Jan 2020
- Last trade
- 1 Jan 2026
- Last filed
- 5 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jan 2026filed 5 Jan 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —27,322 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —27,322 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —49,383 at $0.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —3,333 at $0.00 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Jan 2022filed 29 Apr 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Jan 2021filed 9 Apr 2021 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | —50,000 at $0.00 | filing |
| 1 Jan 2020filed 13 Mar 2020 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | —50,000 at $0.00 | filing |
News
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) versus 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 17 Oct 2026Critical Survey: Fortress Biotech (NASDAQ:FBIO) vs. 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Kevin Lorenz; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.